Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1995-02-17
1997-06-10
Guzo, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 6, 4353201, C12Q 170, C12Q 168, C12N 701
Patent
active
056374569
ABSTRACT:
The present invention relates generally to the area of quality control for recombinant agents to be used in gene therapy. Specifically, the invention concerns an assay used to identify the percentage of defective or therapeutically inactive vector in a vector stock.
REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 4975365 (1990-12-01), Grossman et al.
patent: 5212057 (1993-05-01), Moyer et al.
International Search Report from PCT/US 96/02042, dated Jun. 26, 1996.
Abstract Book, 53rd Annual Meeting of The American Diabetes Association, Las Vegas Convention Center, Las Vegas, Nevada, Jun. 12-15, 1993.
Berkner, "Development of Adenovirus Vectors for the Expression of heterologous Genes," BioTechniques, 6(7):616-629, 1988.
Bett et al., "An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3," Proc. Natl. Acad. Sci. USA, 91:8802-8806, Sep., 1994.
Bishop, "The Molecular Genetics of Cancer," Science, 235:305-311, Jan., 1987.
Blau, "Muscling in on gene therapy," Nature, 364:673-675, Aug., 1993.
Bredenbeek et al., "Sindbis Virus Expression Vectors: Packaging of RNA Replicons by Using Defective Helper RNAs," Journal of Virology, 67(11):6439-6446, Nov., 1993.
Bridge et al., "Adenovirus Early Region 4 and Viral DNA Synthesis," Virology, 193:794-801, 1993.
Casey et al., "Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene," Oncogene, 6:1791-1797, 1991.
Challberg and Ketner, "Deletion Mutants of Adenovirus 2: Isolation and Initial Characterization of Virus Carrying Mutations Near the Right End of the Viral Genome," Virology, 114:196-209, 1981.
Cox et al., "Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptons without toxicity," Nature, 364:725-729, Aug., 1993.
Deuring et al., "An unusual symmetric recombinant between adenovirus type 12 DNA and human cell DNA," Proc. Natl. Acad. Sci. USA, 78(5):3142-3146, May, 1981.
Fields and Jang, "Presence of a Potent Transcription Activating Sequence in the p53 Protein," Science, 249:1046-1049, Aug., 1990.
Friedmann, "Gene Therapy of Cancer through Restoration of Tumor-Suppressor Functions?," Cancer (Supplement), 70(6):1810-1817, Sep., 1992.
Friedmann, "Progress Toward Human Gene Therapy," Science, 244:1275-1281, Jun., 1989.
Fujiwara et al., "Induction of Chemosensitivity in Human Lung Cancer Cells in Vivo by Adenovirus-mediated Transfer of the Wild-Type p53 Gene," Cancer Research, 54:2287-2291, May, 1994.
Gluzman and Van Doren, "Palindromic Adenovirus Type 5-Simian Virus Hybrid," Journal of Virology, 45(1):91-103, Jan., 1983.
Ghosh-Choudhury et al., "Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes," The EMBO Journal, 6(6):1733-1739, 1987.
Ghosh-Choudhury and Graham, "Stable Transfer of a Mouse Dihydrofolate Reductase Gene Into A Deficient Cell Line Using Human Adenovirus Vector," Biochemical and Biophysical Research Communications, 147(3):964-973, Sep., 1987.
Glorioso et al., "Herpes simplex virus-based vectors," Virology, 3:265-276, 1992.
Gomez-Foix et al., "Adenovirus-mediated Transfer of the Muscle Glycogen Phosphorylase Gene into Hepatocytes Confers Altered Regulation of Glycogen Metabolism," The Journal of Biological Chemistry, 267(35):25129-25134, Dec. 1992.
Graham and Prevec, "Adenovirus-Based Expression Vectors and Recombinant Vaccines," W. Doerfler (ed.), Adenovirus DNA, Martinus Nijhoff Publishing, Boston, pp. 363-390, 1986.
Grunhaus and Horwitz, "Adenoviruses as cloning vectors," Virology, 3:237-252, 1992.
Hearing and Shenk, "Functional Analysis of the Nucleotide Sequence Surrounding the Cap Site for Adenovirus Type 5 Region E1A Messenger RNAs," J. Mol. Biol., 167:809-822, 1983.
Hearing et al., "Identification of a Repeated Sequence Element Required for Efficient Encapsidation of the Adenovirus Type 5 Chromosome," Journal of Virology, 2555-2558, Aug., 1987.
Hermonat and Muzyczka, "Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells," Proc. Natl. Acad. Sci. USA, 81:6466-6470, Oct., 1984.
Herz and Gerard, "Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice," Proc. Natl. Acad. Sci. USA, 90:2812-2816, Apr., 1993.
Hollstein et al., "p53 Mutations in Human Cancers," Science, 253:49-53, 1991.
Ishibashi et al., "Hypercholesterolemia in Low Density Lipoprotein Receptor Knockout Mice and its reversal by Adenovirus-mediated Gene Delivery," J. Clin. Invest., 92:883-893, Aug., 1993.
Jaffe et al., "Adenovirus-mediated in vivo gene transfer and expression in normal rat liver," Nature Genetics, 1:372-378, Aug., 1992.
Ketner et al., "Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and detection plasmids," Nucleic Acids Research, 17(8), 3037-3049, 1989.
La Salle et al., "An Adenovirus Vector for Gene Transfer into Neurons ad Glia in the Brain," Science, 259:988-990, Feb., 1993.
Lebkowski et al., "Adeno-Associated Virus: a Vector System for Efficient Introduction and Integration of DNA into a Variety of Mammalian Cell Types," Molecular and Cellular Biology, 8(10):3988-3996, Oct., 1988.
Lemarchand et al., "Adenovirus-mediated transfer of a recombinant human .alpha..sub.1 -antitrypsin cDNA to human endothelial cells," Proc. Natl. Acad. Sci. USA, 89:6482-6486, Jul., 1992.
Levine, "Tumor Suppressor Genes," BioEssays, 12(2)60-66, Feb., 1990.
Levrero et al., "Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo," Gene, 101:195-202, 1991.
Majors, "Retroviral vectors-strategies and applications," Virology, 3:285-295, 1992.
Mastrangeli et al., "Diversity of Airway Epithelial Cell Targets for In Vivo Recombinant Adenovirus-mediated Gene Transfer," The Journal of Clinical Investigation, Inc., 91:225-234, Jan., 1993.
McGrory et al., "Short Communications: A Simple Technique for the Rescue of Early Region I Mutations into Infectious Human Adenovirus Type 5," Virology, 163:614-617, 1988.
Miller, "Human gene therapy comes of age," Nature, 357:455-460, Jun., 1992.
Morgan et al., "Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy," Nucleic Acids Research, 20(6):1293-1299, 1992.
Mulligan, "The Basic Science of Gene Therapy," Science, 260:926-932, May, 1993.
Prevec et al., "Use of Human Adenovirus-based Vectors for Antigen Expression in Animals," J. gen. Virol., 70:429-434, 1989.
Ragot et al., "Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice," Nature, 361:647-650, Feb., 1993.
Renan, "Cancer genes: current status, future prospects, and applications in radiotherapy/oncology," Radiotherapy and Oncology, 19:197-218, 1990.
Rich et al., "Development and Analysis of Recombinant Adenovirus for Gene Therapy of Cystic Fibrosis," Human Gene Therapy, 4:461-476, 1993.
Rosenfeld et al., "Adenovirus-Mediated Transfer of a Recombinant .alpha.1-Antitrypsin Gene to the Lung Epithelium In Vivo," Science, 252:431-434, Apr., 1991.
Rosenfeld et al., "In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epithelium," Cell, 68:143-155, Jan., 1992.
Samulski et al., "Helper-Free Stocks of Recombinant Adeno-Associated Viruses: Normal Integration Does Not Require Viral Gene Expression," Journal of Virology, 63(9):3822-3828, Sep., 1989.
Spandidos and Anderson, "Oncogenes and Onco-Suppressor Genes: Their Involvement in Cancer," Journal of Pathology, 157:1-10, 1989.
Stratford-Perricaudet et al., "Evaluation of the Transfer and Expression in Mice of an Enzyme-Encoding Gene Using a Human Adenovirus Vector," Human Gene Therapy, 1L241-256, 1990.
Stratford-Perricaudet and Perricaudet, "Gene transfer into animals: the promise of adenovirus," Human Gene Transfer, Eds O. Cohen-Haguenauer, M. Boiron, Colloque INSERT/John Libert Eurotext Ltd., 219:51-61, 1991.
Stratford-Pe
Bracco Laurent
Roth Jack A.
Tocque Bruno
Zhang Wei Wei
Guzo David
Rhone Poulenc Rorer
Schwartzman Robert
The University of Texas Board of Regents
LandOfFree
Rapid test for determining the amount of functionally inactive g does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rapid test for determining the amount of functionally inactive g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rapid test for determining the amount of functionally inactive g will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-763810